​

Funding Round

Series A - Moleculent

Series A - Moleculent

Investment Firm

Overview

Moleculent is the Biotechnology Research company.

Announced Date

Jun 11, 2024

Funding Type

Series A

Highlights

Location

Europe

Social

Investor Lead

ARCH Venture Partners

ARCH Venture Partners

ARCH Venture Partners is a convertible_note and debt and early_stage_venture and late_stage_venture and post_ipo and seed and venture firm.

EIR Ventures

EIR Ventures

EIR Ventures is a early_stage_venture firm.

Participant Investors

2

Investor Name
Participant InvestorEIR Ventures
Participant InvestorARCH Venture Partners

Round Details and Background

Moleculent raised $26000000 on 2024-06-11 in Series A

Moleculent is the Biotechnology Research company.

Company Funding History

1

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jun 11, 2024
Series A - Moleculent
2-26.0M

Recent Activity

There is no recent news or activity for this profile.